Stemline Announces Four SL-401 Presentations at Upcoming ASH Meeting
01. November 2017 09:02 ET
|
Stemline Therapeutics, Inc.
NEW YORK, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers,...